Global X Management Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$468K Buy
8,451
+1,402
+20% +$75.7K 0.01% 706
2018
Q1
$446K Buy
7,049
+1,104
+19% +$71K 0.01% 665
2017
Q4
$364K Buy
5,945
+85
+1% +$5.32K 0.01% 638
2017
Q3
$374K Buy
5,860
+349
+6% +$20.4K 0.01% 614
2017
Q2
$307K Sell
5,511
-83
-1% -$4.52K 0.01% 659
2017
Q1
$304K Buy
5,594
+367
+7% +$20.1K 0.01% 615
2016
Q4
$305K Sell
5,227
-186
-3% -$10.2K 0.01% 518
2016
Q3
$292K Buy
5,413
+4,181
+339% +$269K 0.01% 472
2016
Q2
$91K Buy
1,232
+695
+129% +$49.1K ﹤0.01% 554
2016
Q1
$34K Buy
537
+208
+63% +$13.1K ﹤0.01% 640
2015
Q4
$23K Buy
329
+3
+0.9% +$198 ﹤0.01% 477
2015
Q3
$19K Sell
326
-113
-26% -$7.17K ﹤0.01% 496
2015
Q2
$29K Buy
439
+83
+23% +$5.47K ﹤0.01% 453
2015
Q1
$23K Sell
356
-46
-11% -$2.88K ﹤0.01% 426
2014
Q4
$24K Buy
402
+92
+30% +$5.19K ﹤0.01% 424
2014
Q3
$16K Sell
310
-92
-23% -$4.6K ﹤0.01% 509
2014
Q2
$20K Hold
402
﹤0.01% 504
2014
Q1
$21K Sell
402
-30,688
-99% -$1.63M ﹤0.01% 477
2013
Q4
$1.65M Buy
31,090
+5,220
+20% +$266K 0.14% 161
2013
Q3
$1.2M Buy
25,870
+4,290
+20% +$188K 0.14% 175
2013
Q2
$964K Buy
+21,580
New +$937K 0.16% 150

Other funds holding BMY

Global X Management Company's BMY Position: Q2 2018 in Review

Global X Management Company increased its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2018, buying an estimated $75.7K and bringing the position to 8,451 shares worth $468K. The position accounts for 0.01% of the portfolio, ranked #706.

Global X Management Company first reported a position in BMY in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.65M in Q4 2013. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Global X Management Company held 8,451 shares of Bristol-Myers Squibb worth $468K as of Q2 2018.
  • Global X Management Company bought 1,402 Bristol-Myers Squibb shares in Q2 2018, an estimated $75.7K.
  • Bristol-Myers Squibb made up 0.01% of Global X Management Company's portfolio in Q2 2018, its #706 holding.
  • Global X Management Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 21 quarters since.
  • Global X Management Company's Bristol-Myers Squibb position peaked at $1.65M in Q4 2013.
  • 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.